These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6223451)

  • 41. Depo-Provera may be linked to uterine cancer, preliminary data imply.
    Fam Plann Perspect; 1979; 11(1):47. PubMed ID: 105932
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of non-antiovulatory doses of norethindrone & depoprovera on implantation in rat.
    Guin AK; Datta SC; Das S; Sengupta D
    Indian J Biochem Biophys; 1980 Aug; 17(4):294-7. PubMed ID: 6452400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are Norplant, Depo-Provera good options for nursing mothers?
    Contracept Technol Update; 1993 Mar; 14(3):46-8. PubMed ID: 12318085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemical effect of non-antiovulatory doses of different progestins on cycling rat uterus.
    Guin AK; Das S; Datta SC; Dey S; Sengupta D
    Indian J Exp Biol; 1980 Apr; 18(4):355-7. PubMed ID: 6156897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should depot medroxyprogesterone acetate be considered for additional uses?
    Kinch RA
    Can Med Assoc J; 1982 Nov; 127(10):947-8. PubMed ID: 7139435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New year, new option: Cyclo-Provera awaits word.
    Contracept Technol Update; 1998 Jan; 19(1):3-4. PubMed ID: 12348212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Int J Cancer; 1991 Sep; 49(2):186-90. PubMed ID: 1831802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depo-Provera highly effective as injectable contraceptive.
    Denniston GC
    Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Depo-Provera: the jury still out.
    Gold RB
    Fam Plann Perspect; 1983; 15(2):78-81. PubMed ID: 6231191
    [No Abstract]   [Full Text] [Related]  

  • 50. Injectable contraception: the USA perspective.
    Kaunitz AM
    IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Depo-Provera debate. Commentary on the article "Depo-Provera, a critical analysis".
    Benagiano G; Fraser I
    Contraception; 1981 Nov; 24(5):493-528. PubMed ID: 6459209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS
    J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
    Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
    East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Controversy over Depo-Provera.
    Wash Drug Device Lett; 1977 Jan; 9(1):2. PubMed ID: 12335988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depot medroxyprogesterone acetate contraception in women with medical problems.
    Frederiksen MC
    J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Injectable medroxyprogesterone.
    Rosenfield AG
    Drug Ther (NY); 1975 Jul; 5():139. PubMed ID: 12229496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Injectable hormones and regulatory controversy: an end to the long-running story?
    Klitsch M
    Fam Plann Perspect; 1993; 25(1):37-40. PubMed ID: 8432375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera.
    Halpern V; Brache V; Taylor D; Lendvay A; Cochón L; Jensen JT; Dorflinger LJ
    Fertil Steril; 2021 Apr; 115(4):1035-1043. PubMed ID: 33485608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Lobo RA; McCormick W; Singer F; Roy S
    Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.